Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disorders.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disorders.
- Published In:
- Neuropeptides, 114, 102564 (2025)
- Authors:
- Gołyszny, Miłosz, Dragon, Jonasz, Obuchowicz, Ewa
- Database ID:
- RPEP-11164
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11164APA
Gołyszny, Miłosz; Dragon, Jonasz; Obuchowicz, Ewa. (2025). Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disorders.. Neuropeptides, 114, 102564. https://doi.org/10.1016/j.npep.2025.102564
MLA
Gołyszny, Miłosz, et al. "Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disorders.." Neuropeptides, 2025. https://doi.org/10.1016/j.npep.2025.102564
RethinkPeptides
RethinkPeptides Research Database. "Role of interplay between endocannabinoids and neuropeptides..." RPEP-11164. Retrieved from https://rethinkpeptides.com/research/golyszny-2025-role-of-interplay-between
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.